Clover Health Investments saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Clover Health Investments‘s patent filings and grants. Buy the databook here.
Clover Health Investments has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent grants with nearly 100% of grants. The United States(US) patent Office are among the top ten patent offices where Clover Health Investments is filings its patents. Among the top granted patent authorities, Clover Health Investments has 100% of its grants in United States(US).
International Business Machines and Siemens could be the strongest competitors for Clover Health Investments
Patents related to electronic medical record (emr) systems and healthtech lead Clover Health Investments's portfolio
Clover Health Investments has the highest number of patents in electronic medical record (emr) systems followed by, healthtech and data analytics. For electronic medical record (emr) systems no patents were filed and 25% of patents were granted in Q2 2024.
Medical imaging information systems related patents lead Clover Health Investments portfolio followed by electronic document mgmt, and data & database management
Clover Health Investments has highest number of patents in medical imaging information systems followed by electronic document mgmt, data & database management, databases.
For comprehensive analysis of Clover Health Investments's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.